Pfizer announces it is launching a clinical trial to study the effectiveness of its COVID-19 antiviral pill in young children.
MORE: Ivermectin, condemned by experts as COVID-19 treatment, continues to be easily accessible through telemedicine
"Since the beginning of the pandemic, more than 11 million children under the age of 18 in the United States alone have tested positive for COVID-19, representing nearly 18% of reported cases and leading to more than 100,000 hospital admissions," Mikael Dolsten, chief scientific officer and president of worldwide research, development and medical at Pfizer, said in a"There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help...
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: